| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/02/2003 | EP1270010A2 Use of Macrophage Inflammatory Protein-4 or a fragment thereof for treating adult respiratory distress syndrome |
| 01/02/2003 | EP1269990A1 Cosmetic or dermatological composition comprising acylaminoamide derivatives |
| 01/02/2003 | EP1269989A1 Cosmetic or dermatological composition comprising acylaminoamide derivatives |
| 01/02/2003 | EP1269988A1 Cosmetic or dermatological composition comprising acylaminoamide derivatives |
| 01/02/2003 | EP1269860A1 Pharmaceutical composition |
| 01/02/2003 | EP1269196A1 Method of screening for inhibitors of osteopontin |
| 01/02/2003 | EP1269183A1 Assay for agents that induce chemokinesis |
| 01/02/2003 | EP1269180A1 Methods for screening and identifying pathogen virulence factors |
| 01/02/2003 | EP1268854A1 High specificity marker detection |
| 01/02/2003 | EP1268835A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 01/02/2003 | EP1268821A2 Helicase inhibitors |
| 01/02/2003 | EP1268820A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/02/2003 | EP1268818A2 18221, dual specificity phosphatase and uses thereof |
| 01/02/2003 | EP1268814A2 Regulation of human leucine aminopeptidase-like enzyme |
| 01/02/2003 | EP1268811A2 Pi3k - regulatory subunit homologue |
| 01/02/2003 | EP1268806A1 Clostridium difficile polypeptides and uses thereof |
| 01/02/2003 | EP1268804A2 Helical protein zalpha51 |
| 01/02/2003 | EP1268803A2 Bi-functional cancer treatment agents |
| 01/02/2003 | EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 01/02/2003 | EP1268800A2 Mucin-1 specific binding members and methods of use thereof |
| 01/02/2003 | EP1268798A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 01/02/2003 | EP1268797A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/02/2003 | EP1268795A2 Regulation of human mas oncogene-related g protein-coupled receptor |
| 01/02/2003 | EP1268794A2 Compositions and methods related to canine igg and canine il-13 receptors |
| 01/02/2003 | EP1268793A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/02/2003 | EP1268792A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 01/02/2003 | EP1268791A2 Brca-1 regulators and methods of use |
| 01/02/2003 | EP1268790A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/02/2003 | EP1268789A2 Human leucine-rich repeat family member and uses thereof |
| 01/02/2003 | EP1268787A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 01/02/2003 | EP1268786A2 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis |
| 01/02/2003 | EP1268785A2 Gtp-binding protein gamma-12 subunit |
| 01/02/2003 | EP1268784A2 Genes involved in intestinal inflammatory diseases and use thereof |
| 01/02/2003 | EP1268783A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 01/02/2003 | EP1268782A2 Apolipoprotein-a-i regulation of t-cell signalling |
| 01/02/2003 | EP1268781A2 G12l, a gene associated with the thermal response |
| 01/02/2003 | EP1268779A1 Regulation of human galanin receptor-like g protein coupled receptor |
| 01/02/2003 | EP1268778A1 Materials and methods relating to a novel splice variant of a na + dependent glutamate transporter |
| 01/02/2003 | EP1268776A2 Corneodesmosin based test and model for inflammatory disease |
| 01/02/2003 | EP1268775A1 The high bone mass gene of 11q13.3 |
| 01/02/2003 | EP1268773A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 01/02/2003 | EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 01/02/2003 | EP1268771A1 Human gata-5 transcription factor |
| 01/02/2003 | EP1268768A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/02/2003 | EP1268762A1 Novel nucleic acids and polypeptides |
| 01/02/2003 | EP1268760A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 01/02/2003 | EP1268756A2 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 01/02/2003 | EP1268753A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 01/02/2003 | EP1268554A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 01/02/2003 | EP1268549A2 Method of identifying inhibitors of tie-2 |
| 01/02/2003 | EP1268548A2 Regulation of human rta-like g protein-coupled receptor |
| 01/02/2003 | EP1268547A2 Methods of modulating drug clearance mechanisms by altering sxr activity |
| 01/02/2003 | EP1268546A2 G protein-coupled receptors |
| 01/02/2003 | EP1268544A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 01/02/2003 | EP1268543A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268542A2 Therapeutic anti-melanoma compounds |
| 01/02/2003 | EP1268541A1 7 human ovarian and ovarian cancer associated proteins |
| 01/02/2003 | EP1268540A2 Proteins amf-1 to amf-10 and nucleic acids encoding same |
| 01/02/2003 | EP1268534A2 Peptides binding to non-acetylated h3 and h4 histones for cancer therapy |
| 01/02/2003 | EP1268530A1 Hepatitis b core antigen fusion proteins |
| 01/02/2003 | EP1268529A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 01/02/2003 | EP1268528A2 Human genes and expression products |
| 01/02/2003 | EP1268526A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/02/2003 | EP1268525A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 01/02/2003 | EP1268523A2 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 01/02/2003 | EP1268522A2 Novel lhrh-antagonists, production and use thereof as medicament |
| 01/02/2003 | EP1268521A1 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268520A2 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268519A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/02/2003 | EP1268518A1 Insulin potentiating peptides |
| 01/02/2003 | EP1268510A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268509A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 01/02/2003 | EP1268507A1 Antisense modulation of e2f transcription factor 1 expression |
| 01/02/2003 | EP1268502A1 O-aryl glucoside sglt2 inhibitors and method |
| 01/02/2003 | EP1268498A1 Cardioprotective phosphonates and malonates |
| 01/02/2003 | EP1268495A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 01/02/2003 | EP1268494A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 01/02/2003 | EP1268493A1 Phosphoramidate prodrugs |
| 01/02/2003 | EP1268481A2 Kinase inhibitors as therapeutic agents |
| 01/02/2003 | EP1268434A1 Cyclic lactams as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268433A1 Cyclic lactams as inhibitors of a-beta-protein production |
| 01/02/2003 | EP1268424A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/02/2003 | EP1268414A1 Ceramide derivatives and method of use |
| 01/02/2003 | EP1268405A1 Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents |
| 01/02/2003 | EP1268096A1 Extrusion die |
| 01/02/2003 | EP1268000A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 01/02/2003 | EP1267999A1 Stable thyroid hormone preparations and method of making same |
| 01/02/2003 | EP1267954A1 Medical devices suitable for gene therapy regimens |
| 01/02/2003 | EP1267946A2 Nanocapsule encapsulation system and method |
| 01/02/2003 | EP1267944A1 Systemic gene delivery vehicles for the treatment of tumors |
| 01/02/2003 | EP1267942A2 Chemically modified novel erythropoietin stimulating protein compositions and methods |
| 01/02/2003 | EP1267940A1 Compounds for targeting |
| 01/02/2003 | EP1267934A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 01/02/2003 | EP1267933A2 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 01/02/2003 | EP1267928A2 Methods for immunostimulation using bispecific binding agents for the fc receptor of immunoglobulin a and for cancer cells or infectious antigen |
| 01/02/2003 | EP1267927A1 Methods of therapy for non-hodgkin's lymphoma using a combination of an antibody to cd20 and interleukin-2 |
| 01/02/2003 | EP1267925A1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 01/02/2003 | EP1267921A1 Composition and method for the prevention and/or the treatment of allergy |
| 01/02/2003 | EP1267918A1 Method of treatment using ligand-immunogen conjugates |